MARKET

HROWL

HROWL

Harrow Health
NASDAQ
25.27
-0.03
-0.12%
Opening 14:39 05/19 EDT
OPEN
25.25
PREV CLOSE
25.30
HIGH
25.30
LOW
25.20
VOLUME
9.80K
TURNOVER
--
52 WEEK HIGH
25.49
52 WEEK LOW
22.52
MARKET CAP
--
P/E (TTM)
-41.6310
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at HROWL last week (0512-0516)?
Weekly Report · 14h ago
Weekly Report: what happened at HROWL last week (0505-0509)?
Weekly Report · 05/12 10:58
HARROW, INC. <HROW.O>: H.C. WAINWRIGHT RAISES TARGET PRICE TO $60 FROM $57
Reuters · 05/12 10:08
U.S. RESEARCH ROUNDUP-Amphastar Pharmaceuticals, Comstock, Range Resources
Reuters · 05/12 07:48
HARROW ANNOUNCES FIRST-QUARTER 2025 FINANCIAL RESULTS
Reuters · 05/08 20:01
HARROW HEALTH Q1 REVENUE USD 47.8 MILLION VS. IBES ESTIMATE USD 57 MILLION
Reuters · 05/08 20:01
Weekly Report: what happened at HROWL last week (0428-0502)?
Weekly Report · 05/05 11:00
What Recession? I'm Swimming In Dividends
Seeking Alpha · 04/29 11:35
More
About HROWL
Harrow, Inc. is an eyecare pharmaceutical company. The Company is engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the United States market. It provides a comprehensive portfolio of prescription and non-prescription pharmaceutical products. It owns commercial rights to portfolios of branded ophthalmic pharmaceutical products in North America, all of which are marketed under the Harrow name. It owns and operates ImprimisRx, an ophthalmology-focused pharmaceutical-compounding business. It owns United States commercial rights to various products: IHEEZO, VEVYE, TRIESENCE, VIGAMOX, ILEVRO, FLAREX, NATACYN, ZERVIATE, and others. VIGAMOX (moxifloxacin hydrochloride ophthalmic solution) 0.5%, a fluoroquinolone antibiotic eye drops for the treatment of bacterial conjunctivitis caused by susceptible strains of organisms. IHEEZO (chloroprocaine hydrochloride ophthalmic gel) 3% is a low-viscosity gel indicated for ocular surface anesthesia.

Webull offers Harrow Inc stock information, including NASDAQ: HROWL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HROWL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HROWL stock methods without spending real money on the virtual paper trading platform.